Sera from cancer patients contain two oscillating ECTO-NOX activities with different period lengths
- PMID: 12565167
- DOI: 10.1016/s0304-3835(02)00616-x
Sera from cancer patients contain two oscillating ECTO-NOX activities with different period lengths
Abstract
ECTO-NOX protein's are cell surface-associated and growth-related hydroquinone oxidases with both protein disulfide-thiol interchange activity and the capacity to oxidize NAD(P)H. The activities of these ECTO-NOX proteins are not steady state but fluctuate to create a repeating pattern of oscillations. Two forms of ECTO-NOX activities have been distinguished. The constitutive ECTO-NOX (CNOX), is hormone responsive and refractory to quinone-site inhibitors. A tumor-associated NOX (tNOX) is unregulated, refractory to hormones and growth factors and responds to quinone-site inhibitors. CNOX proteins are widely distributed and exhibit oscillations in enzymatic activity with a period length of 24 min. tNOX proteins are cancer specific and exhibit oscillations with a period length of about 22 min. Our findings now demonstrate the presence of the novel oscillating tNOX activity in sera of patients with cancer whereas the constitutive NOX of non-cancer cells is present in sera of both cancer patients and healthy volunteers. We conclude that ECTO-NOX proteins in sera exhibit oscillatory characteristics similar to those of ECTO-NOX forms of the cell surface.
Similar articles
-
NADH oxidase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms.Biochim Biophys Acta. 2001 Jun 20;1539(3):192-204. doi: 10.1016/s0167-4889(01)00107-0. Biochim Biophys Acta. 2001. PMID: 11420117
-
Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases.Free Radic Res. 2003 Aug;37(8):795-808. doi: 10.1080/1071576031000083107. Free Radic Res. 2003. PMID: 14567438 Review.
-
ECTO-NOX target for the anticancer isoflavene phenoxodiol.Oncol Res. 2007;16(7):299-312. doi: 10.3727/000000006783980973. Oncol Res. 2007. PMID: 17518268
-
Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients.Cancer Immunol Immunother. 2002 May;51(3):121-9. doi: 10.1007/s00262-001-0262-2. Epub 2002 Feb 27. Cancer Immunol Immunother. 2002. PMID: 11941450 Free PMC article.
-
Spotlight on tNOX: a tumor-selective target for cancer therapies.Drug News Perspect. 2006 May;19(4):223-5. doi: 10.1358/dnp.2006.19.4.1007077. Drug News Perspect. 2006. PMID: 16823496 Review.
Cited by
-
Capsaicinoids and Their Effects on Cancer: The "Double-Edged Sword" Postulate from the Molecular Scale.Cells. 2023 Nov 4;12(21):2573. doi: 10.3390/cells12212573. Cells. 2023. PMID: 37947651 Free PMC article. Review.
-
Selected Office Based Anticancer Treatment Strategies.J Oncol. 2019 Jan 15;2019:7462513. doi: 10.1155/2019/7462513. eCollection 2019. J Oncol. 2019. PMID: 30766601 Free PMC article. Review.
-
Benzo[b]thiophenesulphonamide 1,1-dioxide derivatives inhibit tNOX activity in a redox state-dependent manner.Br J Cancer. 2005 Feb 28;92(4):690-5. doi: 10.1038/sj.bjc.6602383. Br J Cancer. 2005. PMID: 15685230 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
